Novel Gemcitabine-Re(I) bisquinolinyl complex combinations and formulations with liquid crystalline nanoparticles for pancreatic cancer photodynamic therapy
With less than 10% of 5-year survival rate, pancreatic ductal adenocarcinoma (PDAC) is known to be one of the most lethal types of cancer. Current literature supports that gemcitabine is the first-line treatment of PDAC. However, poor cellular penetration of gemcitabine along with the acquired and i...
Saved in:
Main Authors: | Liew, Hui Shan, Mai, Chun-Wai, Zulkefeli, Mohd, Madheswaran, Thiagarajan, Kiew, Lik Voon, Pua, Lesley Jia Wei, Hii, Ling Wei, Lim, Wei Meng, Low, May Lee |
---|---|
Format: | Article |
Published: |
Frontiers Media
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41630/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BODIPY dyes in photodynamic therapy
by: Kamkaew, Anyanee, et al.
Published: (2013) -
Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation
by: Kiew, Lik Voon, et al.
Published: (2010) -
Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy
by: Ng, Xiao Ying, et al.
Published: (2024) -
Traditional and novel adiposity indicators and pancreatic cancer risk: Findings from the UK women's cohort study
by: Shyam, Sangeetha, et al.
Published: (2021) -
Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition
by: Obon-Santacana, Mireia, et al.
Published: (2020)